Literature DB >> 15233504

Use of the SF-36 in the evaluation of a drug detoxification program.

Dirk Richter1, Bernd Eikelmann, Klaus Berger.   

Abstract

OBJECTIVE: The aim of this study was to analyse whether the SF-36 questionnaire is a useful tool to evaluate the treatment outcome of a drug detoxification program.
METHODS: A pre post assessment of consecutive referrals to a drug detoxification program of a psychiatric state hospital in north-western Germany was conducted. Seventy-nine males and twenty-one females with a diagnosis of multiple substance use were included. MOS short form 36 (SF-36) was used upon admission and discharge to assess changes in self-perceived health status. Severity scales from the addiction severity interview (ASI) were used to rate severity of illness by a physician at program entry.
RESULTS: Patients with severe comorbidity (hepatitis B, depression, attempted suicide) reported significant worse health states, compared to those without. Positive correlations between physician rated addiction severity and patients' self-perceived health status were observed, most strongly for mental health status. For the 48 patients with 2 assessments significant improvements during the treatment period were observed on SF-36 subscales 'general health' and 'physical functioning'. Patients with severe physical and/or mental problems upon admission had more benefits from treatment than patients without.
CONCLUSIONS: SF-36 questionnaire is a useful instrument to monitor the health status and to evaluate treatment effects in drug addicts.

Entities:  

Mesh:

Year:  2004        PMID: 15233504     DOI: 10.1023/B:QURE.0000025589.07313.46

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  18 in total

1.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

2.  Complaints that predict drop-out from a detoxification and counselling unit.

Authors:  J E Berg; J I Brevik
Journal:  Addict Behav       Date:  1998 Jan-Feb       Impact factor: 3.913

3.  State of the science of mental health and substance abuse patient outcomes assessment.

Authors:  G R Smith
Journal:  New Dir Ment Health Serv       Date:  1996

Review 4.  Regression towards the mean, historically considered.

Authors:  S M Stigler
Journal:  Stat Methods Med Res       Date:  1997-06       Impact factor: 3.021

5.  Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment.

Authors:  M Torrens; L San; A Martinez; C Castillo; A Domingo-Salvany; J Alonso
Journal:  Addiction       Date:  1997-06       Impact factor: 6.526

6.  Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices.

Authors:  K B Wells; C D Sherbourne
Journal:  Arch Gen Psychiatry       Date:  1999-10

7.  Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study.

Authors:  R L Spitzer; K Kroenke; M Linzer; S R Hahn; J B Williams; F V deGruy; D Brody; M Davies
Journal:  JAMA       Date:  1995-11-15       Impact factor: 56.272

8.  Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire.

Authors:  C F Ryan; J M White
Journal:  Addiction       Date:  1996-01       Impact factor: 6.526

9.  An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.

Authors:  A T McLellan; L Luborsky; G E Woody; C P O'Brien
Journal:  J Nerv Ment Dis       Date:  1980-01       Impact factor: 2.254

10.  German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment.

Authors:  M Bullinger
Journal:  Soc Sci Med       Date:  1995-11       Impact factor: 4.634

View more
  9 in total

1.  An assessment of factorial structure and health-related quality of life in problem drug users using the Short Form 36 Health Survey.

Authors:  Angela Buchholz; Anneke Krol; Fred Rist; Pythia T Nieuwkerk; Gerard M Schippers
Journal:  Qual Life Res       Date:  2008-07-12       Impact factor: 4.147

2.  Quality of life among treatment seeking methamphetamine-dependent individuals.

Authors:  Rachel Gonzales; Alfonso Ang; Deborah C Glik; Richard A Rawson; Stella Lee; Martin Y Iguchi
Journal:  Am J Addict       Date:  2011-05-31

3.  Examining unidimensionality and improving reliability for the eight subscales of the SF-36 in opioid-dependent patients using Rasch analysis.

Authors:  Yu-Yu Hsiao; Ching-Lin Shih; Wan-Hui Yu; Cheng-Hsi Hsieh; Ching-Lin Hsieh
Journal:  Qual Life Res       Date:  2014-08-07       Impact factor: 4.147

4.  Health-related quality of life among prescription opioid-dependent patients: Results from a multi-site study.

Authors:  Margaret L Griffin; Heather E Bennett; Garrett M Fitzmaurice; Kevin P Hill; Scott E Provost; Roger D Weiss
Journal:  Am J Addict       Date:  2015-03-24

5.  Quality of life of outpatients in methadone maintenance treatment clinics.

Authors:  Lin Xiao; Zunyou Wu; Wei Luo; Xiaoli Wei
Journal:  J Acquir Immune Defic Syndr       Date:  2010-02       Impact factor: 3.731

6.  Clinical correlates of health-related quality of life among opioid-dependent patients.

Authors:  Kevin C Heslin; Judith A Stein; Keith G Heinzerling; Deyu Pan; Christine Magladry; Ron D Hays
Journal:  Qual Life Res       Date:  2011-02-17       Impact factor: 4.147

7.  Health-related quality of life in urban surgical emergency department patients: comparison with a representative German population sample.

Authors:  Bruno Neuner; Peter M Miller; Bodo Felsmann; Edith Weiss-Gerlach; Tim Neumann; Klaus Dieter Wernecke; Claudia Spies
Journal:  Health Qual Life Outcomes       Date:  2005-12-01       Impact factor: 3.186

8.  Quality of life in patients with personality disorders seen at an ordinary psychiatric outpatient clinic.

Authors:  Kjersti Narud; Arnstein Mykletun; Alv A Dahl
Journal:  BMC Psychiatry       Date:  2005-02-20       Impact factor: 3.630

9.  Safety and tolerability of sauna detoxification for the protracted withdrawal symptoms of substance abuse.

Authors:  Richard D Lennox; Marie Cecchini-Sternquist
Journal:  J Int Med Res       Date:  2018-09-13       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.